|
Invited Speakers:
|
|
Keynote Presentations:
Misguiding Cues used by Viruses to Thwart Protective Immunity:Lessons for Tumor Immunity
Ellis L. Reinherz MD, Professor of Medicine, Harvard Medical School; Director, Cancer Vaccine Center and Chief, Laboratory of Immunobiology, Dana Farber Cancer Institute, USA New Vaccine Technologies: A Regulatory Perspective
Jon R. Daugherty, Ph.D., U.S. Public Health Service, Senior Regulatory Review
Officer, Office of Vaccines Research and Review, CBER/FDA Targeting Toll-Like Receptor 9 for Cancer Therapy
Arthur M. Krieg, M.D., Founder & Chief Scientific Officer, Coley Pharmaceutical Group Inc., USA Exploit Inflammation to Induce Anti-Tumor Immunity: Old Weapons and New Effector Mechanisms
Sven Brandau, Ph.D., Head, Division of Immunotherapy, Department of Immunology and Cell Biology, Research Center Borstel, Germany
Featured Presentation:
Adjuvanting DNA Vaccines
David B. Weiner, Ph.D., Chair, Gene Therapy and Vaccines Program, CAMB, Department of Pathology, University of Pennsylvania School of Medicine more speakers on website
|
|